Cargando…
Impact of Glucocorticoid Receptor Gene Polymorphisms on the Metabolic Profile of Adult Patients with the Classical Form of 21-Hydroxylase Deficiency
BACKGROUND: CAH patients have an increased risk of cardiovascular disease, and it remains unknown if lifelong glucocorticoid (GC) treatment is a contributing factor. In the general population, glucocorticoid receptor gene (NR3C1) polymorphisms are associated with an adverse metabolic profile. Our ai...
Autores principales: | Moreira, Ricardo P. P., Gomes, Larissa G., Mendonca, Berenice B., Bachega, Tânia A. S. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445550/ https://www.ncbi.nlm.nih.gov/pubmed/23028665 http://dx.doi.org/10.1371/journal.pone.0044893 |
Ejemplares similares
-
Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2011) -
Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Gomes, Larissa G., et al.
Publicado: (2013) -
Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
por: Moreira, Ricardo P. P., et al.
Publicado: (2014) -
The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene
por: Moura-Massari, Vivian Oliveira, et al.
Publicado: (2016) -
Impact of Long-Term Dexamethasone Therapy on the Metabolic Profile of Patients With 21-Hydroxylase Deficiency
por: Seraphim, Carlos E, et al.
Publicado: (2019)